Memantine for Epileptic Encephalopathy
Condition(s):Epileptic Encephalopathy, Childhood-OnsetLast Updated:May 1, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Epileptic Encephalopathy, Childhood-OnsetLast Updated:May 1, 2020Recruiting
Condition(s):SchizophreniaLast Updated:December 14, 2015Unknown status
Condition(s):Down Syndrome; Intellectual DisabilityLast Updated:July 28, 2020Completed
Condition(s):Bipolar DisorderLast Updated:October 3, 2019Recruiting
Condition(s):Alzheimer DiseaseLast Updated:May 30, 2017Unknown status
Condition(s):EpilepsyLast Updated:June 4, 2020Completed
Condition(s):Malignant Central Nervous System Neoplasm; Primary Central Nervous System NeoplasmLast Updated:May 14, 2020Recruiting
Condition(s):Sickle Cell DiseaseLast Updated:November 1, 2019Recruiting
Condition(s):Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger’s Disorder; Asperger’s; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)Last Updated:August 7, 2014Completed
Condition(s):Autism Spectrum DisorderLast Updated:March 25, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.